Damora Therapeutics (DMRA) Common Equity (2019 - 2026)
Damora Therapeutics (DMRA) recorded Common Equity of $516.06 million in Q2 2026, compared with $10.95 million a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Damora Therapeutics reported Common Equity of $240.38 million.
- Annual Common Equity has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $15.83 million in FY2024 (-51.0%), $32.33 million in FY2023 (-47.6%), $61.75 million in FY2022 (-47.3%) and $117.22 million in FY2021 (-29.2%).
- The Q2 2026 figure is the highest quarterly Common Equity in data going back to Q3 2019.
- Across the past five years, year-over-year decline in Common Equity ran from 29.2% in Q4 2021 to 61.8% in Q3 2025.
- Per Business Quant, the preceding three quarters came in at $511.6 million (Q1 2026), $240.38 million (Q4 2025) and $8.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Damora Therapeutics | 1.28 Bn | -57.65 Mn | - | 516.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 516.06 Mn |
| Mar 31, 2026 | 511.60 Mn |
| Dec 31, 2025 | 240.38 Mn |
| Sep 30, 2025 | 8.01 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 13.71 Mn |
| Dec 31, 2024 | 15.83 Mn |
| Sep 30, 2024 | 20.94 Mn |
| Jun 30, 2024 | 23.59 Mn |
| Mar 31, 2024 | 28.16 Mn |
| Dec 31, 2023 | 32.33 Mn |
| Sep 30, 2023 | 37.38 Mn |
| Jun 30, 2023 | 43.70 Mn |
| Mar 31, 2023 | 50.33 Mn |
| Dec 31, 2022 | 61.75 Mn |
| Sep 30, 2022 | 72.73 Mn |
| Jun 30, 2022 | 85.07 Mn |
| Mar 31, 2022 | 101.31 Mn |
| Dec 31, 2021 | 117.22 Mn |
| Sep 30, 2021 | 129.62 Mn |
API Access
Damora Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();